Quote:Trump Is Starting to Panic
- By Frank Rich
Since the Democrats made gains in last week’s election — and, in some places, may continue to make more still — Donald Trump has retreated into what the Los Angeles Times calls “a cocoon of bitterness and resentment,” canceling travel plans, lashing out at allies and adversaries, meddling in the remaining undecided races and, apparently, sitting for hours of meetings with his personal lawyers. Should we take his tantrums as an early indicator of additional bad news?
I will make the reckless prediction that “Donald Trump” and “good news” are not fated to appear in the same sentence unless the good news happens to be that his presidency is ending.
Everything about his behavior since the midterms suggests that even he has figured this out. It has belatedly dawned on him that (a) he lost the election he thought he won; (b) the Robert Mueller investigation has moved faster than his efforts to thwart it; (c) any of his legislative fantasies, notably the funding of his border wall, are doomed; and (d) and his pouting in Paris elevated his international image as a buffoon to a whole new level of notoriety.
Remember when Republicans attacked Barack Obama (falsely) for allegedly barring Winston Churchill’s bust from the White House? Now the GOP’s hero is a president whom Churchill’s own grandson, the Conservative member of Parliament Nicholas Soames, has labeled “pathetic,” “inadequate,” and “not fit to represent this great country” after Trump failed to show up at the French cemetery rites honoring the fallen of World War I.
That all this makes Trump panic at some gut level is visible not merely in his widely reported spells of rage and bitterness and in his increasingly empty official schedule.
He is also stepping up his already impressive efforts to discredit and destroy those democratic institutions that might prevent him from escaping criminal jeopardy. And so he has returned to ridiculing the very lifeblood of America, the electoral process, by declaring elections that don’t go his way a fraud; he has escalated his assault on a free press by barring a CNN reporter and trying to frame him as a fellow misogynistic bully with a deceptively edited video; and, last but not least, he has appointed an acting attorney general, Matthew Whitaker, who has ridiculed the judicial system, been on the board of a fly-by-night company that practiced Trump University–style consumer frauds, and publicly attacked the Mueller probe in Trump’s own language.
This is bunker behavior. Only a desperate man would try to derail Mueller by installing this transparent reprobate at the Department of Justice.
Even more revealing is how Trump has become more and more unhinged since making his Whitaker move. The growing fury, most manifest in his latest anti-Mueller tweetstorm this week, suggests that he already realizes that the ploy has backfired.
It seems to be finally sinking in, perhaps under the frantic tutelage of his lawyers, that his fate and the fates of his son and son-in-law, among others in his immediate orbit, are tied to the fates of Roger Stone, Michael Cohen, Michael Flynn, Paul Manafort, and all the other president’s men whose comprehensive narrative Mueller is bound to tell America no matter what Trump and his stooge at Justice do to try to foil or decapitate him.
MORE:
nymag.com/intelligencer/2018/11/frank-rich-trump-is-starting-to-panic.html
Trump Is Starting to Panic - By Frank Rich
Top 10 Most Recent News Articles
FDA Greenlights Halozyme's Cancer Treatment Breakthrough
FDA's Seal of Approval: A Game Changer Well, folks, here's a twist in the story of cancer treatment with FDA giving a nod to RYBREVANT FASPRO. Johnson & Johnson's latest offering, fueled by Halozyme's groundbreaking ENHANZE technology, just snagged accelerated approval. We're not just talking any old treatment here; it's a dual-targeted therapy for head and neck cancer...
Continue Reading
Investor Bidding on Off-Market Homes Surges 35% Higher
Investor Frenzy in Off-Market Real Estate Looking at the real estate puzzle today, one might spot an unexpected surge in enthusiasm for off-market residential properties. We've got iFinder Offers, a real estate platform that's made it its business to connect the dots between homeowners and a gaggle of over 325 hungry investors. And according to their magic spreadsheets,...
Continue Reading
CalExitNow Push for CA GOP Ban & Sovereignty Talks
California's Political Pot Stirs In the wild world of politics, California stands as a fiery beacon yet again. This time, CalExitNow, a fiery group championing California's self-determination, is taking aim at the state’s Republican Party. Reminds me of a stock under pressure—hesitate at your peril as the winds of change sweep through. Disqualification Petition: A...
Continue Reading
INOVIO's $75M Offering: A Tough Medicine for Investors
A Shot in the Arm or a Sore Spot? INOVIO Pharmaceuticals is diving headfirst into the capital markets with a $75 million public offering, and let me tell you, the road ahead isn't paved with gold, yet. They've set out to raise funds by pricing 58,747,235 shares at $1.05 a pop, which might have you scratching your head if you're holding INO shares already. Breaking Down...
Continue Reading
AiNET Prevails in Breach of Contract Jury Verdict
AiNET's Legal Triumph Shakes Up the IT Sector Well, talk about a courtroom drama. Greenberg Traurig just snagged a big win for AiNET over in Prince George's County, Maryland, and it's a classic reminder that due diligence isn't just a nice-to-have—it's a must. AiNET found itself in the center of a breach of contract brawl with Tech Finance Co., and guess what? The jury...
Continue Reading
Lilly's Digital Healthcare Push with Hims & Hers
Revolutionizing Access: Pharmaceuticals Meet Telehealth In an era where digital disruption is shaking every sector, Eli Lilly (NYSE:LLY) isn't sitting idle. They've just forged a partnership with Hims & Hers (NYSE:HIMS), one that's diving headfirst into the telehealth revolution. We're talking a slick merger of pharmaceuticals and digital platforms—offering FDA-approved...
Continue Reading
Everest Group Faces Class Action: Key Investor Moves
Everest Group's Legal Spiral: What's Happening? Folks, when a company feels like it's caught in an endless storm, investors better hold on tight. That's the situation Everest Group, Ltd. finds itself in, with an 11.4% stock dive that’s got investors reeling. Securities fraud allegations are rocking Everest like a hurricane, and The Law Offices of Frank R. Cruz have put...
Continue Reading
Brian Long Exits Atlantic Bridge for US Tech Fund
Well, here we go again with another shake-up in the tech investment world. Brian Long, a name that's been whispered around more than a few boardroom tables, is dropping out of Atlantic Bridge to start his own gig across the pond in the United States. If you're tracking numbers, Atlantic Bridge is juggling a healthy €1.4bn in assets—no small potatoes. So, let's dig...
Continue Reading
LaserAway Opens 241st Clinic, Marks 20-Year Milestone
LaserAway's New Chapter in Paramus Out of the glitz of Los Angeles and into the hustle of Paramus, LaserAway's latest clinic isn't just a ribbon-cutting ceremony—it's a milestone in the aesthetic dermatology space. Boasting its 241st location, LaserAway is marking twenty years of relentless expansion without ever closing a single clinic. Now that's a track record that'd...
Continue Reading
TELUS Targets Debt Reduction Amid Telecom Transformation
Adjusting Strategy Amid Financial Challenges The market's a tough beast, and TELUS seems to be wrestling with it, showing both grit and foresight in its latest quarterly update. Third quarter 2026 has TELUS down on revenues with a notable net loss but don't count them out yet. Their Transformation Strategy is a gamble worth watching. Where the Numbers Stand Here's the...
Continue ReadingTop 5 Most Recently Viewed Articles
Jersey Mike's Subs Goes Public with Tasty IPO Plans
Alright, so here's the deal with Jersey Mike's Subs. These folks are storming into the stock market with an IPO that's about to get everyone talking. They're offering a meaty stack of shares—43,478,261 to be exact—hoping to lure investors into a world where sandwiches aren't just a food item, but an experience. Slide into that booth and get your wild predictions...
Continue Reading
Unlocking AI Potential: MicroStrategy's Latest Innovations
MicroStrategy's New Release Enhances AI Personalization MicroStrategy Incorporated (NASDAQ: MSTR), renowned for revolutionizing business intelligence through AI, has unveiled an innovative update to MicroStrategy ONE. This cutting-edge release is designed to help organizations quickly extract value from generative AI (GenAI), tailoring the AI experience to meet the...
Continue Reading
Explore Orbit Local's Revolutionary AI-Driven Marketing Solutions
Unlocking Business Potential with AI-Driven Solutions Orbit Local proudly introduces an innovative Marketing Automation and CRM platform powered by Artificial Intelligence. This robust solution is crafted to assist businesses in enhancing lead generation, improving customer engagement, and ultimately driving sales. With a seamless integration of automation features, AI...
Continue Reading
HORNE Foundation Delivers Generous Support for Charities
HORNE Community Foundation Gives Back to Four Non-Profits $100,000 in total giving benefits organizations from across the United States. Recently, HORNE, a professional services firm, demonstrated its commitment to community support by announcing generous donations to four charities. These contributions, fulfilling specific missions, total $100,000 and aid organizations...
Continue Reading
Surge in Solar Energy Market in Canada Driven by Innovation
Significant Growth in the Solar Energy Market The solar energy market in Canada is experiencing remarkable evolution, with projections indicating an increase in size by approximately USD 2.25 billion during the period from 2025 to 2029. This growth is driven primarily by government initiatives and increasing acceptance of solar power as a viable and sustainable energy...
Continue Reading